APOC3 Protein (Myc-DYKDDDDK Tag)
Kurzübersicht für APOC3 Protein (Myc-DYKDDDDK Tag) (ABIN2714826)
Target
Alle APOC3 Proteine anzeigenProtein-Typ
Spezies
Quelle
Applikation
Reinheit
-
-
Aufreinigungstag / Konjugat
- Dieses APOC3 Protein ist gelabelt mit Myc-DYKDDDDK Tag.
-
Produktmerkmale
-
- Recombinant human Apolipoprotein C III / ApoC3 protein expressed in HEK293 cells.
- Produced with end-sequenced ORF clone
-
-
Möchten Sie weitere Optionen für dieses Protein ?
!Entdecken Sie unsere vordefinierten maßgeschneiderten Proteine und Proteinservices!Ihr Projekt erfordert weitere Anpassungen? Kontaktieren Sie uns und entdecken Sie unsere maßgeschneiderten Proteinlösungen
-
-
-
Applikationshinweise
-
Recombinant human proteins can be used for:
Native antigens for optimized antibody production
Positive controls in ELISA and other antibody assays -
Kommentare
-
The tag is located at the C-terminal.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 50 μg/mL
-
Buffer
- 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10 % glycerol.
-
Lagerung
- -80 °C
-
Informationen zur Lagerung
- Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.
-
-
-
Static and turnover kinetic measurement of protein biomarkers involved in triglyceride metabolism including apoB48 and apoA5 by LC/MS/MS." in: Journal of lipid research, Vol. 55, Issue 6, pp. 1179-87, (2016) (PubMed).
: "
-
Static and turnover kinetic measurement of protein biomarkers involved in triglyceride metabolism including apoB48 and apoA5 by LC/MS/MS." in: Journal of lipid research, Vol. 55, Issue 6, pp. 1179-87, (2016) (PubMed).
-
- APOC3 (Apolipoprotein C-III (APOC3))
-
Andere Bezeichnung
- Apolipoprotein C III (Apo Ciii)
-
Hintergrund
- Apolipoprotein C-III is a very low density lipoprotein (VLDL) protein. APOC3 inhibits lipoprotein lipase and hepatic lipase it is thought to delay catabolism of triglyceride-rich particles. The APOA1, APOC3 and APOA4 genes are closely linked in both rat and human genomes. The A-I and A-IV genes are transcribed from the same strand, while the A-1 and C-III genes are convergently transcribed. An increase in apoC-III levels induces the development of hypertriglyceridemia.
-
Molekulargewicht
- 8.7 kDa
-
NCBI Accession
- NP_000031
-
Pathways
- Carbohydrate Homeostasis, Lipid Metabolism
Target
-